EFIB returns to Brussels. From 27 to 29 October the European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) returns to Europe’s capital, where it was first launched 7 years ago, taking place at the Square, Brussels meeting center. Since then, the event has grown tenfold in size but remains true to its goal of providing the premier meeting place for business and policy throughout the biobased value chain.
There is a new partnership in the world bioeconomy. German Biotec GmbH and Japanese Kaneka Corporation signed a broad Joint Development Agreement for the application of biopolymers. Biotec develops and manufactures bio-based, biodegradable and compostable compounds under the trade name Bioplast. Kaneka is the producer of a 100% bio based and innovative PHBH polymer with the brand name Aonilex, which is new to the market. Both companies agreed to combine development resources to create new bio-based compounds for the application fields of pharmaceutical capsules, extrusion coated paper and cardboard, various other flexible and rigid films and packaging solutions.
The Italian bioeconomy is growing. Bio-on, an innovative industrial biotech company, and Eridania Sadam, sub-holding of the agro-food sector owned by the Maccaferri Group of Bologna, will work together on defining and optimising the production of levulinic acid, a key molecule for the sustainable and low-impact future of the chemical industry. Already available on the international market, but in insufficient quantities, levulinic acid is currently obtained from industrial processes with an environmental impact that fails to meet European standards.
Despite the dramatic recent weakening in global energy markets, ongoing economic expansion in Asia – particularly in China and India – will drive continued growth in the world’s demand for energy over the next 20 years. According to the new edition of the BP Energy Outlook 2035, global demand for energy is expected to rise by 37% from 2013 to 2035, or by an average of 1.4% a year.
Dear Readers,
let me talk about us, to share with you an acknowledgment that we are very pleased to receive. Our blog is considered a model to follow in a scientific paper entitled “Gearing Modeling of Regional Eco-Bio-Logistic Components in Bioeconomic Management, Using Arena Simulation Software”, written by Claudiu Pîrnău, a researcher of the University of Sibiu (Romania), and presented last year at the Scientific Papers International Conference on Knowledge Society.
Investment funds are looking with more attention to the bioeconomy. British bioengineering firm Synthace has closed a £2.2 million funding round with new investors SOSventures, Bioeconomy Capital and Rainbow Seed Fund joining Sofinnova Partners and other existing investors.
VWR, a US leading, independent provider of laboratory products, services and solutions, announced that it has acquired National Biochemicals (NBC), a full service raw material manufacturer and supplier to the biochemical industry. This acquisition will enhance VWR’s growing custom chemical and biochemical manufacturing portfolio, building upon previous successful acquisitions in this segment.
French Global Bioenergies, one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation, announces having reached the first milestone of the BioMA+ project which is financed by the French “Investissements d’Avenir” State program. The project aims at developing a renewable value chain to methacrylic acid, a key constituent of acrylic paints. Achieving this first milestone result unlocks a €1.7 million payment.
Royal DSM, the global Life Sciences and Materials Sciences company headquartered in The Netherlands, announced yesterday a “substantial investment” in its Wilmington, Massachusetts (USA) manufacturing facility in order to produce waterborne resins for inks and coatings. Driven by its commitment to grow the sustainable coatings market, DSM will
upgrade its facilities to produce state-of-the-art waterborne resins for inks and coatings.
Chemical giant Basf has decided to exit the current R&D collaboration with Novozymes and Cargill to develop a bio-based process for producing 3-hydroxypropionic (3-HP) and acrylic acid from renewable raw materials.
IL BIOECONOMISTA 